Murphey v. United States of America et al
Filing
60
ORDER granting Defendants' Motions to Dismiss (Doc. 31 , 40 ). The Court dismisses the First Amended Complaint without leave to amend. IT IS FURTHER ORDERED directing the Clerk to enter judgment accordingly and close this case. Signed by Judge John J Tuchi on 3/28/2024. (KJ)
1
WO
2
3
4
5
6
IN THE UNITED STATES DISTRICT COURT
7
FOR THE DISTRICT OF ARIZONA
8
9
Jennifer N. Murphey,
Plaintiff,
10
11
v.
12
United States of America, et al.,
13
No. CV-22-01224-PHX-JJT
ORDER
Defendants.
14
15
Plaintiff brought this case against the United States, several members of the federal
16
government in their official capacities, and the Arizona Attorney General seeking
17
declaratory and injunctive relief for constitutional and administrative infirmities with the
18
Controlled Substances Act, the Arizona Controlled Substances Act, the 1961 Single
19
Convention on Narcotic Drugs, and the 1971 Convention on Psychotropic Substances.
20
Defendants have filed Motions to Dismiss (Doc. 31, “State Mot.”; Doc. 40, “U.S. Mot.”),
21
to which Plaintiff has filed Responses (Doc. 45, “State Resp.”; Doc. 44, “U.S. Resp.”) and
22
Defendants have filed Replies (Doc. 51, “State Reply”; Doc. 53, “U.S. Reply”).1 For the
23
following reasons, the Court grants Defendants’ Motions to Dismiss.
24
I.
BACKGROUND
25
Plaintiff Jennifer N. Murphey, an attorney in Oro Valley, Arizona who represents
26
herself in this matter, alleges she currently cultivates, possesses, and uses “personal
27
The issues have been fully briefed, and oral argument will not aid in the Court’s
decision. See Fed. R. Civ. P. 78(b) (permitting resolution of motions without oral hearings);
LRCiv 7.2(f) (same).
1
28
1
amounts of psilocybin mushrooms, ayahuasca, iboga, marijuana, [and] coca leaves,” “all
2
of which are controlled and/or implicated under the [Controlled Substances Act, 21 U.S.C.
3
§ 801 et seq. (“CSA”), the Arizona Controlled Substances Act, A.R.S. § 36-2501 et seq.
4
(“AZCSA”), the 1961 Single Convention on Narcotic Drugs, the 1971 Convention on
5
Psychotropic Substances,] and related criminal provisions.” (Doc. 22, First Am. Compl.
6
(“FAC”) ¶ 136.) In this lawsuit, she is suing the United States and its Attorney General,
7
the Administrator of the U.S. Drug Enforcement Agency (“DEA”), the Secretary of the
8
U.S. Department of Health and Human Services, and the Arizona Attorney General.
9
In the FAC, the operative pleading, Plaintiff claims the named statutes and
10
Conventions violate (1) her due process rights under the Fifth Amendment of the U.S.
11
Constitution, (2) her free speech rights under the First Amendment of the U.S. Constitution,
12
(3) her First Amendment and due process rights under the Fourteenth Amendment of the
13
U.S. Constitution (by way of 42 U.S.C. § 1983), (4) her due process rights under Article 2
14
of the Arizona State Constitution, (5) her free speech rights under Article 2 of the Arizona
15
State Constitution, (6) the Commerce Clause and the Necessary and Proper Clause of the
16
U.S. Constitution, (7) the Tenth Amendment of the U.S. Constitution, and (8) the
17
Administrative Procedure Act, 5 U.S.C. § 706 (“APA”). Defendants have now moved to
18
dismiss the FAC.
19
II.
LEGAL STANDARD
20
A.
Rule 12(b)(1) Motion to Dismiss
21
Federal Rule of Civil Procedure 12(b)(1) authorizes a court to dismiss claims over
22
which it lacks subject matter jurisdiction. Fed. R. Civ. P. 12(b)(1). A Rule 12(b)(1)
23
challenge may be either facial or factual. White v. Lee, 227 F.3d 1214, 1242 (9th Cir. 2000).
24
When, as here, a defendant argues that the claims in the complaint, even if true, are
25
insufficient to establish subject matter jurisdiction, the challenge is a facial one. Safe Air
26
for Everyone v. Meyer, 373 F.3d 1035, 1039 (9th Cir. 2004). In a facial challenge to subject
27
matter jurisdiction under Rule 12(b)(1), courts must accept all material, non-conclusory
28
-2-
1
allegations in the complaint as true and construe the complaint in favor of the plaintiff.
2
White, 227 F.3d at 1242; Maya v. Centex Corp., 658 F.3d 1060, 1068 (9th Cir. 2011).
3
When evaluating a Rule 12(b)(1) motion, the plaintiff bears the burden of
4
establishing the elements of Article III standing. See Spokeo v. Robins, 578 U.S. 330, 338
5
(2016). Because federal courts are courts of limited jurisdiction, “[i]t is to be presumed that
6
a cause lies outside this limited jurisdiction, and the burden of establishing the contrary
7
rests upon the party asserting jurisdiction.” Kokkonen v. Guardian Life Ins. Co. of Am., 511
8
U.S. 375, 377 (1994) (citations omitted).
9
B.
Rule 12(b)(6) Motion to Dismiss
10
Rule 12(b)(6) is designed to “test[] the legal sufficiency of a claim.” Navarro v.
11
Block, 250 F.3d 729, 732 (9th Cir. 2001). A dismissal under Rule 12(b)(6) for failure to
12
state a claim can be based on either: (1) the lack of a cognizable legal theory; or (2) the
13
absence of sufficient factual allegations to support a cognizable legal theory. Balistreri v.
14
Pacifica Police Dep’t, 901 F.2d 696, 699 (9th Cir. 1990). When analyzing a complaint for
15
failure to state a claim, the well-pled factual allegations are taken as true and construed in
16
the light most favorable to the nonmoving party. Cousins v. Lockyer, 568 F.3d 1063, 1067
17
(9th Cir. 2009). A plaintiff must allege “enough facts to state a claim to relief that is
18
plausible on its face.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). “A claim has
19
facial plausibility when the plaintiff pleads factual content that allows the court to draw the
20
reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v.
21
Iqbal, 556 U.S. 662, 678 (2009) (citing Twombly, 550 U.S. at 556). “The plausibility
22
standard is not akin to a ‘probability requirement,’ but it asks for more than a sheer
23
possibility that a defendant has acted unlawfully.” Id.
24
“While a complaint attacked by a Rule 12(b)(6) motion does not need detailed
25
factual allegations, a plaintiff’s obligation to provide the grounds of his entitlement to relief
26
requires more than labels and conclusions, and a formulaic recitation of the elements of a
27
cause of action will not do.” Twombly, 550 U.S. at 555 (cleaned up and citations omitted).
28
Legal conclusions couched as factual allegations are not entitled to the assumption of truth
-3-
1
and therefore are insufficient to defeat a motion to dismiss for failure to state a claim. Iqbal,
2
556 U.S. at 679–80. However, “a well-pleaded complaint may proceed even if it strikes a
3
savvy judge that actual proof of those facts is improbable, and that ‘recovery is very remote
4
and unlikely.’” Twombly, 550 U.S. at 556 (quoting Scheuer v. Rhodes, 416 U.S. 232, 236
5
(1974)).
6
III.
ANALYSIS
7
A.
8
The United States contends that Plaintiff lacks standing to bring her claims in this
9
lawsuit. Under Article III of the Constitution, a plaintiff must have “the core component of
10
standing” to bring a justiciable lawsuit into federal court.” Lujan v. Defs. of Wildlife, 504
11
U.S. 555, 560 (1992). To satisfy Article III’s standing requirements, the plaintiff must show
12
that she suffered a “concrete and particularized” injury that is “fairly traceable to the
13
challenged action of the defendant,” and that a favorable decision would likely redress the
14
injury. Friends of the Earth, Inc. v. Laidlaw Env’t Servs. (TOC), Inc., 528 U.S. 167, 180–
15
81 (2000). In her complaint, the plaintiff must “alleg[e] specific facts sufficient” to
16
establish standing. Schmier v. U.S. Court of Appeals for Ninth Circuit, 279 F.3d 817, 821
17
(9th Cir. 2002). If the plaintiff fails to allege such facts, the Court should dismiss the
18
complaint. See, e.g., Chandler v. State Farm Mut. Auto. Ins. Co., 598 F.3d 1115, 1123 (9th
19
Cir. 2010). Here, the United States focuses on the first prong of the Article III inquiry,
20
arguing that Plaintiff has not shown that she faces a genuine threat of enforcement
21
sufficient to constitute an injury-in-fact. (U.S. Mot. at 4.)
Standing
22
To satisfy the “irreducible constitutional minimum of standing,” an injury must not
23
only be “concrete and particularized,” but also “actual or imminent.” Lujan, 504 U.S. at
24
560. Thus, an injury that is only possible is not enough—there must be a “substantial risk”
25
that the harm will occur. See Susan B. Anthony List v. Driehaus, 573 U.S. 149, 158 (2014).
26
That the plaintiff need demonstrate a “substantial risk” of injury is particularly relevant
27
where, as here, the plaintiff seeks pre-enforcement review such that she alleges “an
28
intention to engage in a course of conduct arguably affected with a constitutional interest
-4-
1
but proscribed by a statute, and there exists a credible threat of prosecution thereunder.”
2
Babbitt v. United Farm Workers Nat’l Union, 442 U.S. 289, 298 (1979).
3
1.
Challenge to CSA, AZCSA, and Related Criminal Statutes
4
The United States contests the existence of a credible threat of prosecution. It is well
5
settled that a plaintiff need not “first expose [herself] to actual arrest or prosecution to be
6
entitled to challenge [the] statute that [she] claims deters the exercise of his constitutional
7
rights.” Steffel v. Thompson, 415 U.S. 452, 459 (1974). Instead, the Ninth Circuit has
8
adopted a three-factor test to determine whether a plaintiff faces a genuine threat of
9
enforcement. See Arizona v. Yellen, 34 F.4th 841, 849 (9th Cir. 2022).
10
To determine whether a claimed threat of enforcement is genuine, courts consider
11
whether: (1) the plaintiff has “articulated a concrete plan to violate the law in question,”
12
(2) “prosecuting authorities have communicated a specific warning or threat to initiate
13
proceedings,” and (3) there is a “history of past prosecution or enforcement under the
14
challenged statute.” Id. at 850. The United States argues that Plaintiff’s FAC “satisfies none
15
of the three factors.” (U.S. Mot. at 6.)
16
Regarding the first factor, a plaintiff’s plan to violate the law need not be “cast in
17
stone,” but “[a] general intent to violate a statute” is not enough to constitute “an
18
articulated, concrete plan.” Thomas v. Anchorage Equal Rts. Comm’n, 220 F.3d 1134, 1139
19
(9th Cir. 2000) (en banc). The United States suggests that Plaintiff has merely asserted a
20
general intent to violate the CSA, (U.S. Mot. at 6), but Plaintiff has done more. In the FAC,
21
Plaintiff states that she currently cultivates, possesses, and/or uses “psilocybin mushrooms,
22
ayahuasca, iboga, marijuana, [and] coca leaves” in her home and that she intends to
23
continue doing so. (FAC ¶ 136.) Each of these substances is currently controlled under one
24
of the five established schedules of the CSA. See 21 U.S.C. § 812. Plaintiff has thus
25
admitted to engaging in conduct proscribed by the CSA.
26
Where a plaintiff is “currently violating and plan[s] to continue to violate the CSA
27
by” consuming a controlled substance, that plaintiff satisfies the concrete plan factor. See
28
Oklevueha Native Am. Church of Hawaii, Inc. v. Holder, 676 F.3d 829, 836 (9th Cir. 2012).
-5-
1
Plaintiff need “not state exactly how, where, and in what quantities [she] intend[s] to
2
consume” controlled substances to have sufficiently alleged a concrete plan. Id. at 835.
3
Consequently, Plaintiff satisfies the first factor.2
4
Under the second factor, “the threat of enforcement must at least be ‘credible,’ not
5
simply ‘imaginary or speculative.’” Thomas, 220 F.3d at 1140 (quoting Babbitt, 442 U.S.
6
at 298). The United States argues that because Plaintiff has not directly received a specific
7
warning or threat to initiate proceedings against her, the Court should reject standing. (U.S.
8
Mot. at 8.) However, the second factor requires no such direct threat of prosecution. See
9
Valle del Sol Inc. v. Whiting, 732 F.3d 1006, 1015 n.5 (9th Cir. 2013). Indeed, “[o]ne does
10
not have to await the consummation of threatened injury to obtain preventive relief.”
11
Blanchette v. Conn. Gen. Ins. Corps., 419 U.S. 102, 143 (1974). It is enough for the plaintiff
12
to “intend[] to engage in a course of conduct arguably affected with a constitutional interest
13
and that there is a credible threat that the challenged provision will be invoked against the
14
plaintiff.” LSO, Ltd. v. Stroh, 205 F.3d 1146, 1155 (9th Cir. 2000) (internal quotations and
15
citation omitted).
16
Here, Plaintiff faces a credible threat that the criminal provisions of the CSA or its
17
state-based counterpart will be enforced against her. Courts routinely find standing where
18
enforcement authorities have failed to disavow enforcement of the law in question. See
19
Virginia v. Am. Booksellers Ass’n, Inc., 484 U.S. 383, 393 (1988); Yellen, 34 F.4th at 850
20
(“That the federal government has not disavowed enforcement of the [provision] is
21
evidence of an intent to enforce it.”). Plaintiff alleges that she has spoken to state officials
22
and “neither the State nor any of its municipalities has agreed to set forth any action that
23
would stop or minimize prosecution for certain controlled substances.” (FAC ¶ 138.) The
24
state government declined to disavow enforcement of the AZCSA then, and the United
25
States has declined to disavow enforcement of the CSA now. (U.S. Mot. at 8.) Plaintiff’s
26
27
28
The United States also argues that Plaintiff’s subjective fear of prosecution is
insufficient to confer Article III standing, (U.S. Mot. at 6–8), but the Court need not reach
that argument because the Plaintiff’s admitted use of controlled substances is itself
sufficient.
2
-6-
1
“fear of criminal prosecution under an allegedly unconstitutional statute is not imaginary
2
or wholly speculative.” Babbitt, 442 U.S. at 302.
3
The United States relies on Thomas v. Anchorage Equal Rights Commission for the
4
proposition that “neither the mere existence of a proscriptive statute nor a generalized threat
5
is sufficient.” Thomas, 220 F.3d at 1140. But Thomas is distinguishable. The plaintiffs in
6
Thomas were landlords who pledged to flout anti-discrimination laws by refusing to rent
7
to unmarried couples. Id. at 1137. Those couples, in the plaintiffs’ view, sought to commit
8
the sin of cohabitation by living together. Id. The landlords in that case brought a pre-
9
enforcement challenge to the anti-discrimination laws based on an intent to violate the
10
laws, but the court found any future violation “beyond speculation” due to the landlords’
11
“expressed ‘intent’ to violate the law on some uncertain day in the future—if and when an
12
unmarried couple attempts to lease one of their rental properties.” Id. at 1140. The court
13
rejected standing because “[t]he asserted threat [was] wholly contingent upon the
14
occurrence of unforeseeable events,” such as whether an unmarried couple would seek to
15
lease the landlords’ property or whether an unmarried couple, having been denied tenancy,
16
would complain to enforcement agencies. Id. at 1141.
17
Unlike Thomas, no contingent set of circumstances is required to trace Plaintiff’s
18
plan of using controlled substances to a possible future criminal prosecution. Plaintiff
19
stated that she has violated and will continue to violate the CSA; no attenuated chain of
20
events sits between that concrete plan and a future criminal prosecution. In other words,
21
Plaintiff’s theory of standing does not rely “on a highly attenuated chain of possibilities.”
22
See Clapper v. Amnesty Int’l USA, 568 U.S. 398, 410 (2013).3 Therefore, she satisfies the
23
second factor.
24
Regarding the third factor, courts consider “the history of enforcement under the
25
statute.” Thomas, 220 F.3d at 1140. The United States argues that Plaintiff cannot satisfy
26
27
28
3
In her Response, Plaintiff argues that she faces a credible threat of enforcement
based on “a history of past enforcement against parties similarly situated to the plaintiff.”
(U.S. Resp. at 3 (quoting Lopez v. Candaele, 622 F.3d 1112, 1122 (9th Cir. 2010)).) In its
Reply, the United States correctly points out that the Ninth Circuit withdrew and
superseded that opinion with an amended opinion that rejected standing. (U.S. Reply at 2
(citing Lopez v. Candaele, 630 F.3d 775 (9th Cir. 2010)).) Although the Lopez court did
-7-
1
this factor because she “has evidently not been arrested, charged, or imprisoned because of
2
her narcotics usage.” (U.S. Mot. at 8.) In making this argument, the United States, without
3
citing any authority, impliedly qualifies the third factor by requiring a history of
4
enforcement under the statute against the plaintiff in particular. But no such qualification
5
exists in the Ninth Circuit, and courts look to all instances of enforcement of the statute,
6
even against others. See Thomas, 220 F.3d at 1140; American-Arab Anti-Discrimination
7
Comm. v. Thornburgh, 970 F.2d 501, 508 (9th Cir. 1991).
8
The United States does not argue that it has no history of enforcing the CSA, nor
9
could it. Undisputedly, thousands of prosecutions have been brought under the CSA, as
10
Plaintiff alleges in her Complaint. (FAC ¶ 137.) Thus, Plaintiff satisfies the third factor.
11
Because all three factors weigh in favor of Plaintiff facing a credible threat of enforcement
12
for her past and future use of proscribed controlled substances, she has standing to
13
challenge the CSA, AZCSA, and related criminal provisions.4
14
2.
Challenge to International Conventions
15
Just because a plaintiff has standing to bring some of her claims does not relieve her
16
of demonstrating standing for “each claim [s]he seeks to press and for each form of relief
17
that is sought.” Davis v. Fed. Election Comm’n, 554 U.S. 724, 734 (2008) (internal
18
quotations and citation omitted). Because Plaintiff also challenges the constitutionality of
19
indeed reject the plaintiff’s argument in the amended opinion about a history of past
enforcement against similarly situated parties, the court rejected it based upon factual
differences between the plaintiff and the parties allegedly similar to him. Lopez, 630 F.3d
at 791. The court noted that there was no indication that the defendant even interpreted the
plaintiff’s conduct as having violated its policy such that it would enforce the policy against
him, distinguishing the plaintiff from the allegedly similar individuals. See id at 790–91.
The court did not, as the United States argues, reject the underlying legal premise. See id.
In any event, though it may be sufficient to confer standing, a history of past enforcement
against similarly situated individuals is not necessary. See Cal. Pro-Life Council, Inc. v.
Getman, 328 F.3d 1088, 1094–95 (9th Cir. 2003). Therefore, the Court’s conclusion is
supported by the case law notwithstanding Plaintiff’s erroneous citation.
20
21
22
23
24
25
26
27
28
4
The United States also argues that Plaintiff lacks standing to challenge the entirety
of the CSA. (U.S. Mot. at 9.) But the United States’s cited cases merely stand for the
proposition that a plaintiff must have standing for each cause of action and form of relief
sought. See Town of Chester, N.Y. v. Laroe Ests., Inc., 581 U.S. 433, 439 (2017); Lewis v.
Casey, 518 U.S. 343, 358 (1996). Plaintiff seeks declaratory and injunctive relief
prohibiting the enforcement of the CSA and AZCSA to the extent they prevent her from
producing, possessing, or using certain controlled substances. (FAC at 55–56.) To those
ends, Plaintiff has standing. See Gonzales v. Raich, 545 U.S. 1, 7 (2005).
-8-
1
the 1961 and 1971 Conventions, she must independently have standing for those claims.
2
She does not.
3
When it comes to international treaties, there is a “distinction between treaties that
4
automatically have effect as domestic law, and those that—while they constitute
5
international law commitments—do not by themselves function as binding federal law.”
6
Medellín v. Texas, 552 U.S. 491, 504 (2008). This distinction lays the foundation for the
7
doctrine of self-execution, whereby “a self-executing treaty is one that is judicially
8
enforceable upon ratification,” whereas “a non-self-executing treaty requires congressional
9
action via implementing legislation . . . .” Republic of Marshall Islands v. United States,
10
865 F.3d 1187, 1192 (9th Cir. 2017). In other words, “[n]ot all treaties are created equal in
11
terms of enforceability.” Id. at 1190.
12
The United States argues that the 1961 and 1971 Conventions are not self-executing
13
and, thus, unenforceable in this Court. (U.S. Mot. at 10.) Plaintiff argues, in response, that
14
the Conventions carry “the force of binding domestic law as they were implemented by the
15
CSA.” (U.S. Resp. at 3.) Because neither Convention “serves as a ‘directive to domestic
16
courts,’” the Court agrees with the United States. Marshall Islands, 865 F.3d at 1193
17
(quoting Medellín, 552 U.S. at 508).
18
“The interpretation of a treaty, like the interpretation of a statute, begins with its
19
text.” Medellín, 552 U.S. at 506. Here, Plaintiff points to no text in either the 1961 or 1971
20
Convention that “explicitly call[s] for direct judicial enforcement.” Marshall Islands, 865
21
F.3d at 1195. Plaintiff also fails to identify a provision in either Convention that addresses
22
the manner in which the United States is obligated to enforce criminal prohibitions against
23
the cultivation or use of controlled substances. See id. Nor could she; the 1961 Convention,
24
for example, merely obliges the United States to “take such legislative and administrative
25
measures as may be necessary” to “give effect to and carry out the provisions.” Single
26
Convention on Narcotic Drugs, 1961 art. 4, Mar. 30, 1961, 18 U.S.T. 1407, 520 U.N.T.S.
27
204. Plaintiff fares no better under the 1971 Convention by failing to pinpoint any evidence
28
-9-
1
that “domestic enforcement was explicitly or implicitly contemplated . . . in federal court.”
2
Marshall Islands, 865 F.3d at 1199.
3
Courts are “to give direct legal effect to treaties only insofar as they are self-
4
executing and therefore operate as the law of the land.” Hopson v. Kreps, 622 F.2d 1375,
5
1380 (9th Cir. 1980). Because the 1961 and 1971 Conventions are not self-executing, they
6
are not the law of the land. Thus, they do not serve to impose legal obligations upon
7
Plaintiff that are enforceable in this Court. The result is that Plaintiff has no standing to
8
challenge the Conventions, and the Court must dismiss Plaintiff’s related claims.
9
B.
Due Process
10
Plaintiff alleges that Defendants have violated her substantive and procedural due
11
process rights as guaranteed by the Fifth and Fourteenth Amendments of the U.S.
12
Constitution and Article 2, § 4 of the Arizona State Constitution. (FAC ¶¶ 148–150,
13
154-159.) The United States and Arizona Attorney General raise largely the same arguments
14
supporting their Motions to Dismiss. First, they argue that Plaintiff’s asserted liberty interests
15
are neither sufficiently articulated nor so deeply rooted in history and tradition as to constitute
16
fundamental liberty interests. But, both parties say, even if Plaintiff was able to show as
17
much, her substantive due process claims would still be foreclosed by the Ninth Circuit’s
18
decision in Raich v. Gonzales, 500 F.3d 850 (9th Cir. 2007). Then, Defendants argue,
19
because Plaintiff failed to establish either a protected liberty or property interest, she cannot
20
state a claim for a procedural due process violation either.
21
Under the Fifth and Fourteenth Amendments, the government may not “infringe
22
certain ‘fundamental’ liberty interests . . . unless the infringement is narrowly tailored to
23
serve a compelling state interest.” Reno v. Flores, 507 U.S. 292, 302 (1993). To determine
24
whether an asserted liberty interest is “fundamental,” courts employ a two-step analysis
25
that asks whether: 1) the asserted liberty interest is “objectively, deeply rooted in this
26
Nation’s history and tradition, and implicit in the concept of ordered liberty,” and (2) the
27
plaintiff provides a “careful description” of the asserted fundamental liberty interest.
28
Washington v. Glucksberg, 521 U.S. 702, 720–21 (1997).
- 10 -
1
Though enumerated as the second step of the analysis, courts sometimes “must
2
begin with a careful description of the asserted right, for the doctrine of judicial self-
3
restraint requires us to exercise the utmost care whenever we are asked to break new ground
4
in this field.” Flores, 507 U.S. at 302. Indeed, the Supreme Court “has always been
5
reluctant to expand the concept of substantive due process because guideposts for
6
responsible decisionmaking in this unchartered area are scarce and open-ended.” Collins
7
v. Harker Heights, 503 U.S. 115, 125 (1992). For that reason, the Court must first
8
“carefully formulat[e] the interest at stake.” Glucksberg, 521 U.S. at 722.
9
As Defendants point out, Plaintiff asserts a lengthy list of fundamental liberty
10
interests, ranging from her “interest in exercising [her] personal and mental autonomy by
11
determining and choosing what is best for [her] own mind, body and spirit” to her “interest
12
in informed consent with regard to treatment” and her “interest in meaningful choice with
13
regard to [her] own healthcare and wellbeing.” (FAC ¶¶ 132–34.) Most of those interests are
14
not “carefully stated and narrowly identified” because they omit their “centerpiece”: that
15
Plaintiff seeks the right to use certain controlled substances. See Raich, 500 F.3d at 864.
16
However, the Court can discern one asserted liberty interest in the FAC sufficiently
17
stated to satisfy the requisite level of specificity. See id. n.12 (recognizing the court’s
18
discretion to construe the asserted right as necessary). In her Complaint, Plaintiff
19
specifically asserts the right to “cultivat[e], possess[], and/or us[e] personal amounts of
20
psilocybin mushrooms, ayahuasca, iboga, marijuana, coca leaves, . . . and any other
21
substance [she] choose[s], in [her] own home, to the extent [she] feel[s] is necessary for
22
[her] own well-being, consciousness, and mental and physical health.” (FAC ¶ 136.)
23
Though Plaintiff’s asserted right is capacious and rather broad, the Court accepts this
24
articulation as the “careful description” required by Glucksberg.5
25
With this as Plaintiff’s asserted right, the Court moves on to analyze whether the
26
right is “objectively, deeply rooted in this Nation’s history and tradition.” Glucksberg, 521
27
28
5
The Court notes that, under any formulation of an asserted liberty interest that
includes the use of a controlled substance, the analysis under Raich comes out the same.
- 11 -
1
U.S. at 720–21. That analysis need not be conducted from scratch, however, because Raich
2
is controlling law that binds the Court here.
3
In Raich, the plaintiff was a California resident who consumed marijuana to treat a
4
multitude of maladies. Raich, 500 F.3d at 855. She had “been diagnosed with more than
5
ten serious medical conditions, including an inoperable brain tumor, a seizure disorder,
6
life-threatening weight loss, nausea, and several chronic pain disorders.” Id. After attempts
7
by her doctor to explore “virtually every legal treatment alternative,” the plaintiff resorted
8
to consumption of marijuana as her sole effective remedy. Id. In a pre-enforcement
9
challenge, as in the present case, the plaintiff challenged the constitutionality of the CSA
10
on multiple grounds, one of which being a substantive due process challenge under the
11
Fifth Amendment. Id. at 856.
12
The court rejected the plaintiff’s asserted “right to make a life-shaping decision on
13
a physician’s advice to use medical marijuana to preserve bodily integrity, avoid intolerable
14
pain, and preserve life, when all other prescribed medications and remedies have failed.”
15
Id. at 864–66. Despite acknowledging “that medical and conventional wisdom that
16
recognizes the use of marijuana for medical purposes [was] gaining traction,” the court
17
concluded that “the use of medical marijuana ha[d] not obtained the degree of recognition”
18
necessary to protect the asserted right as fundamentally protected by the Constitution. Id.
19
at 865. Rather, the issue “remain[ed] in the arena of public debate and legislative action.”
20
Id. at 866 (internal quotations and citation omitted).
21
If the right asserted in Raich failed, so too must the right asserted here. Plaintiff
22
asserts that she has the fundamental right to consume psilocybin mushrooms, ayahuasca,
23
iboga, marijuana, coca leaves, and more, but that conduct falls well outside the bounds of
24
the conduct in Raich. Marijuana is but one of the substances Plaintiff wishes to consume,
25
and if the narrower right to use medical marijuana as a last resort is not “implicit in the
26
concept of ordered liberty,” then neither is the broader right to use a myriad of controlled
27
substances as one feels it is “necessary.” See id. Though the Raich court prophesized that
28
“the wisdom of a future day” may soon bring the use of certain controlled substances within
- 12 -
1
the realm of “fundamental” rights, this Court is not permitted to make that call. Id. The
2
Court must abide by the Ninth Circuit precedent in Raich, which has been reaffirmed on
3
multiple occasions. See Wilson v. Lynch, 835 F.3d 1083, 1097 n.9 (9th Cir. 2016); United
4
States v. Langley, 17 F.4th 1273, 1275 (9th Cir. 2021).
5
Plaintiff cites the Supreme Court’s decision in Dobbs v. Jackson Women’s Health
6
Org., 597 U.S. 215 (2022), to highlight the difference between conduct that “involve[]s
7
another person” and conduct that “involves no other.” (U.S. Resp. at 10.) Because Plaintiff
8
asserts a right that “involves intimacy with [her] own mind, body, and spirit,” she purports
9
to have a stronger claim than if her asserted right involved another. (U.S. Resp. at 10.)
10
First, this argument has no effect on the binding nature of Raich. And second, in Dobbs,
11
the Court did not reject the right to abortion simply because it impacted another human.
12
Among other reasons, the Court rejected the right to abortion because it “involved the
13
critical moral question” of ending a “potential life.” Dobbs, 597 U.S. at 257. That question,
14
the Court said, “is fundamentally different” from previously considered privacy interests.
15
Id. at 231. Plaintiff admits in her own Response that a number of other rights are
16
fundamental even when they implicate more than the individual claiming the right. (U.S.
17
Resp. at 10 (“[M]ost of the recognized fundamental rights described above involve another
18
person.”).) Thus, a crisp line cannot be drawn to protect conduct that one keeps to herself
19
while not protecting conduct affecting others. In any event, Dobbs turns farther afield from
20
the direction Plaintiff would have the Court go because the Supreme Court explicitly
21
suggested that illicit drug use “has [no] claim to being deeply rooted in history.” Dobbs,
22
597 U.S. at 257. Though that statement was dicta, it further supports this Court’s decision
23
not to “break new ground in this field.” Flores, 507 U.S. at 302. For the reasons above, the
24
Court must reject Plaintiff’s substantive due process argument and dismiss those claims.
25
In addition to a substantive due process claim, Plaintiff brings a procedural due
26
process claim. It is not entirely clear what the precise basis of Plaintiff’s procedural due
27
process claim is, but the Court understands her to advance the argument that the very
28
existence of the CSA “do[es] not satisfy the procedural due process guarantees of the Fifth
- 13 -
1
Amendment.” (U.S. Resp. at 12–13.) When “action is purely legislative, the statute satisfies
2
due process if the enacting body provides public notice and open hearings.” Gallo v. U.S.
3
Dist. Court For Dist. of Ariz., 349 F.3d 1169, 1181 (9th Cir. 2003) (citing Texaco v. Short,
4
454 U.S. 516, 536 (1982)). Plaintiff makes no allegations that Congress failed to follow
5
proper legislative procedures in enacting the CSA. Thus, the Court also dismisses her
6
procedural due process claim.
7
C.
8
Plaintiff also alleges that Defendants have violated her freedom of speech in
9
contravention of the First Amendment of the U.S. Constitution and Article 2, § 6 of the
10
Arizona State Constitution. (FAC ¶¶ 151–156.) The United States and Arizona Attorney
11
General argue that the challenged CSA provisions “regulate only conduct, not speech,”
12
placing them outside the protections of the First Amendment. (U.S. Mot. at 16–17; State
13
Mot. at 3–4.) Plaintiff resists this conclusion by arguing “that freedom of thought, which
14
naturally includes belief, intention and motivation, are fundamental First Amendment
15
rights” that the CSA unconstitutionally infringes upon. (U.S. Resp. at 13.)
Freedom of Speech
16
The First Amendment guarantees the freedom of expression against intrusion by the
17
government.6 This protection serves “to assure unfettered interchange of ideas for the
18
bringing about of political and social changes desired by the people.” Roth v. United States,
19
354 U.S. 476, 484 (1957). As fundamental as that protection may be, “it is apparent that
20
the unconditional phrasing of the First Amendment was not intended to protect every
21
utterance.” Id. at 483. And though the outer bounds of First Amendment protection extend
22
to situations where an individual chooses to articulate her views through conduct rather
23
than printed or spoken words, it does not reach “an apparently limitless variety of conduct
24
. . . whenever the person engaging in the conduct intends thereby to express an idea.”
25
Spence v. Washington, 418 U.S. 405, 409 (1974).
26
Though “the Arizona Constitution provides broader protections for free speech
than the First Amendment,” the Court analyzes the federal and state free speech claims in
unison. Brush & Nib Studio, LC v. City of Phoenix, 448 P.3d 890, 902 (Ariz. 2019). In her
briefing, Plaintiff does not dispute Defendants’ use of federal case law, and she relies
exclusively on federal case law herself. The Court thus concludes that Plaintiff acquiesces
to combining the analyses.
27
28
6
- 14 -
1
The Ninth Circuit “has eschewed a rule that all conduct is presumptively expressive,
2
[and] individuals claiming the protection of the First Amendment must carry the burden of
3
demonstrating that their nonverbal conduct meets the applicable standard.” Knox v.
4
Brnovich, 907 F.3d 1167, 1181 (9th Cir. 2018) (internal quotations and citation omitted).
5
That applicable standard is set forth in Spence, where the Supreme Court established that
6
“particular conduct possesses sufficient communicative elements to bring the First
7
Amendment into play” when the plaintiff demonstrates that “[a]n intent to convey a
8
particularized message was present, and in the surrounding circumstances the likelihood
9
was great that the message would be understood by those who viewed it.” Spence, 418 U.S.
10
at 410–11.
11
As an initial matter, the Court notes that pure speech is not implicated here. Though
12
Plaintiff cites multiple cases that discuss the sanctity of “an autonomy of self” and the
13
“freedom of thought and belief,” (U.S. Resp. at 13–14), none of those cases support the
14
proposition that ingestion of a controlled substance is speech. Instead, the Court must
15
consider whether ingestion of a controlled substance constitutes expressive conduct under
16
Spence.
17
Plaintiff devotes considerable briefing to critiques of the government’s methods for
18
an alleged “overreach into the private realms of our minds,” but she fails to identify any
19
nonverbal conduct of hers that is intended to convey a particularized message likely to be
20
understood by others. See Spence, 418 U.S. at 410–11. She takes issue with “Defendants’
21
definition of ‘drug abuse,’ the scheduling factors, [and] inspection of personal anecdotes
22
to presume thoughts, intentions, beliefs, . . . and much more.” (U.S. Resp. at 14.) But before
23
considering “whether the State’s regulation is related to the suppression of free
24
expression,” the Court must first assure itself that Plaintiff is “permitt[ed] to invoke the
25
First Amendment” under Spence. Texas v. Johnson, 491 U.S. 397, 403 (1989). Here,
26
Plaintiff has failed to carry her burden of gaining license to invoke the First Amendment
27
because she failed to explain any particularized message that she intends to convey by
28
using controlled substances. See Knox, 907 F.3d at 1181.
- 15 -
1
There do exist scenarios where an individual’s use of a controlled substance may
2
constitute expressive conduct. Plaintiff identifies one such scenario discussed by Justice
3
Alito in his Fulton v. City of Philadelphia, 593 U.S. 522 (2021), concurrence. Justice Alito,
4
referencing Employment Division, Department of Human Resources of Oregon. v. Smith,
5
494 U.S. 872 (1990), noted that “members of the Native American Church who ingest
6
peyote as part of a religious ceremony are surely engaging in expressive conduct that falls
7
within the scope of the Free Speech Clause.” Fulton, 593 U.S. at 561 (Alito, J., concurring).
8
But it does not automatically follow that any action taken with respect to controlled
9
substance use is expressive conduct. See Johnson, 491 U.S. at 405. Courts must place the
10
action into context for purposes of “characterizing such action for First Amendment
11
purposes.” Id. Placed in context, peyote use during a religious ceremony, as in Smith, is
12
distinct from Plaintiff’s generalized intention to use a number of controlled substances as
13
she sees fit.
14
While the CSA prohibits certain conduct associated with controlled substances,
15
Plaintiff’s freedom of speech remains intact. Though she cannot possess controlled
16
substances, she may still advocate for policy changes allowing for their possession. See
17
Speiser v. Randall, 357 U.S. 513, 535 (1958). Though she cannot distribute controlled
18
substances, she retains “the right to receive information and ideas” about them. See Stanley
19
v. Georgia, 394 U.S. 557, 564 (1969). And though she cannot manufacture controlled
20
substances, the CSA does not purport to allow the government to “probe [her] reading
21
habits, political philosophy, beliefs, and attitudes on social and economic issues.” See
22
Schneider v. Smith, 390 U.S. 17, 24 (1968). Because Plaintiff has failed to carry her burden
23
of showing how the CSA infringes on her ability to convey any particularized message, the
24
Court dismisses her freedom of speech claims.
25
D.
26
Commerce Clause, Necessary and Proper Clause, and the Tenth
Amendment
27
Plaintiff also claims Congress exceeded its powers under the Commerce Clause and
28
violated the Necessary and Proper Clause in enacting the CSA and, as a result, also violated
- 16 -
1
the Tenth Amendment provision that powers not delegated by the Constitution to the
2
United States are reserved to the states. (FAC ¶¶ 163–68.) The provision of the Constitution
3
providing that Congress has the power to “regulate commerce . . . among the several states”
4
is referred to as the Commerce Clause. U.S. Const. art. I, § 8, cl. 3. Congress’s legislative
5
power is limited to making laws that are “necessary and proper” for carrying out its
6
constitutional power. U.S. Const. art. I, § 8, cl. 18.
7
In Raich, the Supreme Court held that, in enacting the CSA, Congress violated
8
neither the Commerce Clause nor the Necessary and Proper Clause, but rather it was a
9
“valid exercise of federal power.” 545 U.S. at 8. Plaintiff argues that, in the 18 years since
10
Raich was decided, “substantial new evidence” by way of “vast changes in state marijuana
11
legislation” is available that controverts the Supreme Court’s decision in Raich, including
12
“reduction of federal marijuana trafficking arrests.” (U.S. Resp. at 18–19.) But the Supreme
13
Court found that Congress “had a rational basis for concluding that leaving home-
14
consumed marijuana outside federal control would [affect] price and market conditions,”
15
thereby exerting “a substantial effect on interstate commerce.” 545 U.S. at 17–19. While it
16
may be relevant to current federal policy regarding marijuana regulation, a meaningful
17
review of the “new evidence” cited by Plaintiff does not alter the Supreme Court’s
18
interstate commerce analysis in Raich with regard to Congress’s enactment of the CSA.
19
See id. That analysis applies with equal force now. Thus, “when it enacted comprehensive
20
legislation to regulate the interstate market in a fungible commodity, Congress was acting
21
well within its authority to ‘make all Laws which shall be necessary and proper’ to ‘regulate
22
Commerce. . . among the several States.’” Id. at 22 (quoting U.S. Const. art. I, § 8). “That
23
the regulation ensnares some purely intrastate activity is of no moment.” Id.
24
Where, as here, a plaintiff claims a federal intrusion into state sovereignty, the Tenth
25
Amendment inquiry mirrors the inquiry under the Commerce Clause. See New York v.
26
United States, 505 US. 144, 156 (1992). “If a power is delegated to Congress in the
27
Constitution, the Tenth Amendment expressly disclaims any reservation of that power to
28
- 17 -
1
the States.” Id. Accordingly, because Congress acted within its power in enacting the CSA,
2
Plaintiff’s Tenth Amendment claim also fails.
3
E.
4
Finally, Plaintiff brings a claim under the APA, 5 U.S.C. § 706, to challenge final
5
agency actions of the DEA in implementing the CSA. (FAC ¶¶ 169–71.) The APA provides
6
that a district court may review agency action. 5 U.S.C. § 706. If the court finds that an
7
agency action was “arbitrary, capricious, an abuse of discretion, not in accordance with
8
law, or unsupported by substantial evidence,” the court may reverse or set aside the
9
decision. 5 U.S.C. § 706(2)(a), (e).
Administrative Procedure Act
10
In her brief, Plaintiff states the basis of her APA claim is the DEA’s “pattern of
11
unconstitutional practices and policies that led to the creation of and continuous changes
12
to the schedules in the regulations.” (U.S. Resp. at 7.) Plaintiff contends she is not
13
challenging any “final determinations, findings, and conclusions” subject to review only
14
by a court of appeals under 21 U.S.C. § 877. In particular, Plaintiff states she is not
15
challenging the DEA’s final determinations by way of the scheduling of particular
16
substances (U.S. Resp. at 5–6), even if she goes to great lengths in the FAC to allege the
17
improper scheduling of substances such as Daridorexant and tryptamines (FAC ¶¶ 33–53).
18
But if Plaintiff is not challenging the scheduling of particular substances, it is
19
unclear precisely what final agency actions she is challenging. And while she cites John
20
Doe, Inc. v. Drug Enforcement Administration, 484 F.3d 561, 568 (D.C. Cir. 2007), for the
21
proposition that district courts have reviewed DEA activity as a “final agency action” that
22
was outside § 877’s “final determinations, findings, and conclusions” provision (U.S. Resp.
23
at 6), that court could actually find no basis in this context to conclude a plaintiff could
24
challenge a “final agency action” subject to district court review outside of the “final
25
determinations findings, and conclusions” subject only to court of appeals review under
26
21 U.S.C. § 877. John Doe, Inc., 484 F.3d at 568–69. Moreover, unlike in the present case,
27
the challenged final agency action in that case was clear: the DEA’s denial of a permit to
28
import for bioequivalency testing a generic version of a drug approved by the Food and
- 18 -
1
Drug Administration. Id. at 563. Here, Plaintiff does not identify a final agency action of
2
the DEA with any specificity as a basis of her APA claim.
3
A claim based on each of the other possibilities the Court can glean from the FAC
4
fails. To the extent Plaintiff is challenging the DEA’s implementation of the CSA
5
regulations as a whole—that is, to the extent she “seeks a sweeping injunction against the
6
entire implementing framework” of the CSA, as characterized by the United States (U.S.
7
Reply at 4)—the DEA promulgated the regulations in 1997, and the statute of limitations
8
period for such a claim would have run in 2003, making her current claim untimely.
9
In characterizing her claim as one premised in “unconstitutional practices and
10
policies” of the DEA (U.S. Resp. at 7), Plaintiff argues without citation to legal authority
11
that her challenge is “not within the competence of Defendants to decide” (U.S. Resp. at 5).
12
But her challenge to the constitutionality of the regulations as applied to her activities in
13
producing, possessing or consuming controlled substances mirrors her claims that the CSA
14
itself is unconstitutional, and those claims have no merit, as the Court discussed supra. For
15
all of these reasons, the Court will dismiss Plaintiff’s APA claim.
16
Because the Court finds that Plaintiff cannot cure the defects in the FAC by further
17
amendment, the Court will dismiss the FAC without leave to amend. See Lopez v. Smith,
18
203 F.3d 1122, 1129 (9th Cir. 2000).
19
IT IS THEREFORE ORDERED granting Defendants’ Motions to Dismiss
20
(Doc. 31, 40). The Court dismisses the First Amended Complaint without leave to amend.
21
IT IS FURTHER ORDERED directing the Clerk to enter judgment accordingly
22
23
and close this case.
Dated this 28th day of March, 2024.
24
25
Honorable John J. Tuchi
United States District Judge
26
27
28
- 19 -
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?